miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
出版年份 2020 全文链接
标题
miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 20, Pages 7691
出版商
MDPI AG
发表日期
2020-10-17
DOI
10.3390/ijms21207691
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma‐based microRNA signatures in early diagnosis of breast cancer
- (2020) Xu Li et al. Molecular Genetics & Genomic Medicine
- Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
- (2019) Laura Cantini et al. NUCLEIC ACIDS RESEARCH
- Differential microRNA expression profiles determined by next‑generation sequencing in three fulvestrant‑resistant human breast cancer cell lines
- (2019) Juan Guo et al. Oncology Letters
- Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer– A Comparison
- (2019) Vahid Arabkari et al. PATHOLOGY & ONCOLOGY RESEARCH
- MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer
- (2019) Michael J. G. Milevskiy et al. BRITISH JOURNAL OF CANCER
- Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
- (2019) Peter McAnena et al. BMC CANCER
- Overexpression of microRNA‐190 inhibits migration, invasion, epithelial‐mesenchymal transition, and angiogenesis through suppression of protein kinase B‐extracellular signal‐regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer
- (2019) Guiming Sun et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells
- (2019) Mengjia He et al. ONCOGENE
- Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy
- (2019) Ginés Luengo-Gil et al. CELLULAR ONCOLOGY
- Refinement of breast cancer molecular classification by miRNA expression profiles
- (2019) Rolf Søkilde et al. BMC GENOMICS
- The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines
- (2019) Gizem Örs Kumoğlu et al. GENE
- Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
- (2019) Maria Amorim et al. Frontiers in Genetics
- Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study
- (2019) Line Moi et al. Journal of Translational Medicine
- Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach
- (2019) Erik Kudela et al. Cancers
- Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer
- (2019) Francesca Citron et al. CANCER RESEARCH
- The integrative knowledge base for miRNA-mRNA expression in colorectal cancer
- (2019) Daša Jevšinek Skok et al. Scientific Reports
- miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
- (2019) Yu Gao et al. Scientific Reports
- Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells
- (2018) Qian Zhou et al. ANTI-CANCER DRUGS
- MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3
- (2018) Xiangdong Bai et al. BIOMEDICINE & PHARMACOTHERAPY
- Loss of estrogen-regulated MIR135A1 at 3p21.1 promotes tamoxifen resistance in breast cancer
- (2018) Weijie Zhang et al. CANCER RESEARCH
- Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection
- (2018) Tingting Fan et al. CANCER SCIENCE
- Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study
- (2018) J.L. Ethier et al. EUROPEAN JOURNAL OF CANCER
- miR-125a-3p inhibits ERα transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor–positive breast cancer
- (2018) Lufeng Zheng et al. FASEB JOURNAL
- miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer
- (2018) Pavol Zubor et al. Future Oncology
- A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer
- (2018) Jian Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Anti-microRNA-222 (anti-miR-222) and -181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.
- (2018) Yuanzhi Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA‑663b mediates TAM resistance in breast cancer by modulating TP73 expression
- (2018) Hua Jiang et al. Molecular Medicine Reports
- Molecular Subtypes and Local-Regional Control of Breast Cancer
- (2018) Simona Maria Fragomeni et al. Surgical Oncology Clinics of North America
- Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods
- (2018) Peng Ye et al. Oncology Letters
- Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis
- (2018) Zhicong Chen et al. EBioMedicine
- Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells
- (2018) Jinjing Cun et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1
- (2018) Chenghui Lin et al. OncoTargets and Therapy
- MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
- (2018) Mafalda Rizzuti et al. Scientific Reports
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Aberrant miRNAs expressed in HER-2 negative breast cancers patient
- (2018) Cornelia Braicu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators
- (2018) Bojan Ljepoja et al. BREAST
- MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance
- (2017) Elizabeth C. Martin et al. FEBS LETTERS
- Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer
- (2017) Kouki Tsuboi et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer
- (2017) Cui-Ping Tang et al. ONCOLOGY REPORTS
- MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction
- (2017) Farah J Nassar et al. PHARMACOLOGY & THERAPEUTICS
- MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells
- (2017) Jun Lin et al. Experimental and Therapeutic Medicine
- Mitochondrial calcium uniporter as a target of microRNA-340 and promoter of metastasis via enhancing the Warburg effect
- (2017) Changhui Yu et al. Oncotarget
- Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update
- (2016) Ping Tang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer’
- (2016) Vivian Y Shin et al. BRITISH JOURNAL OF CANCER
- miR-155 Drives Metabolic Reprogramming of ER + Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
- (2016) Marina Bacci et al. CANCER RESEARCH
- Subtype-specific micro-RNA expression signatures in breast cancer progression
- (2016) Vilde D. Haakensen et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer.
- (2016) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
- (2016) Jiang Zhu et al. Cell Death & Disease
- Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer
- (2016) Tejal Joshi et al. Oncotarget
- Profiles of miRNAs matched to biology in aromatase inhibitor resistant breast cancer
- (2016) Reiner Hoppe et al. Oncotarget
- miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer
- (2016) Ye Sol Kim et al. Oncotarget
- MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells
- (2016) Kai Yin et al. Oncotarget
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- Association of miR-1266 with Recurrence/Metastasis Potential in Estrogen Receptor Positive Breast Cancer Patients
- (2015) Elif Demirdogen Sevinc et al. Asian Pacific Journal of Cancer Prevention
- Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
- (2015) Aamir Ahmad et al. BMC CANCER
- The novel role of miRNAs for tamoxifen resistance in human breast cancer
- (2015) Wenwen Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- ceRNA in cancer: possible functions and clinical implications
- (2015) Xiaolong Qi et al. JOURNAL OF MEDICAL GENETICS
- MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
- (2015) Xinfeng Yu et al. Molecular Cancer
- Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development
- (2015) Chuan Jin et al. TUMOR BIOLOGY
- miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A
- (2015) Kazuhiro Ikeda et al. Scientific Reports
- Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas
- (2015) Rajyasree Emmadi et al. PLoS One
- Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells
- (2014) Chandrani Achari et al. BMC CANCER
- Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
- (2014) Yifang Wei et al. BREAST CANCER RESEARCH AND TREATMENT
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
- (2014) Xin Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multiple functions of hypoxia-regulated miR-210 in cancer
- (2014) Qin Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
- (2014) Aoife Ward et al. JOURNAL OF PATHOLOGY
- The multilayered complexity of ceRNA crosstalk and competition
- (2014) Yvonne Tay et al. NATURE
- MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells
- (2014) J Cui et al. ONCOGENE
- miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
- (2014) Elisabetta Crippa et al. PLoS One
- Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer
- (2014) Ailbhe M. McDermott et al. PLoS One
- Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis
- (2014) Jian Wang et al. PLoS One
- Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women
- (2014) Annette R. Kodahl et al. PLoS One
- Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis
- (2013) Jincai Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
- (2013) Reiner Hoppe et al. EUROPEAN JOURNAL OF CANCER
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients
- (2012) Mohamed M. Hafez et al. Asian Pacific Journal of Cancer Prevention
- Expression Analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran
- (2012) Shahram Savad et al. Asian Pacific Journal of Cancer Prevention
- An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells
- (2012) Seungyoon Nam et al. BMC GENOMICS
- miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer
- (2012) Yumi Endo et al. ENDOCRINE-RELATED CANCER
- miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2
- (2012) Jianwen Wei et al. JOURNAL OF CELL BIOLOGY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status
- (2012) Xin Zhou et al. PLoS One
- ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer
- (2012) Irene K. Guttilla et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
- (2011) W. Shi et al. CANCER RESEARCH
- Initial steps of metastasis: Cell invasion and endothelial transmigration
- (2011) Franziska van Zijl et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
- (2011) A Bergamaschi et al. ONCOGENE
- The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells
- (2010) Selma Masri et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression
- (2010) Bao Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells
- (2010) Dario Antonini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers
- (2010) R Hrstka et al. ONCOGENE
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
- (2010) H. M. Heneghan et al. ONCOLOGIST
- Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
- (2008) Fuxiao Xin et al. BIOINFORMATICS
- Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
- (2008) Jeffrey Peppercorn et al. CANCER INVESTIGATION
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search